Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTITUMOR AGENT FOR BLADDER CANCER AND METHOD FOR TREATING BLADDER CANCER
Document Type and Number:
WIPO Patent Application WO/2019/164010
Kind Code:
A1
Abstract:
The problem addressed by the present invention is to provide an antitumor agent for bladder cancer that exhibits an effect on bladder cancer, and a method for treating bladder cancer. The present invention provides an antitumor agent for bladder cancer that contains 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine or a salt or a prodrug thereof.

Inventors:
JANKU FILIP (US)
YAMADA TAKAYUKI (JP)
Application Number:
PCT/JP2019/007242
Publication Date:
August 29, 2019
Filing Date:
February 26, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
FUJIFILM CORP (JP)
International Classes:
A61K31/70; A61K9/08; A61P13/10; A61P35/00
Domestic Patent References:
WO1997038001A11997-10-16
Other References:
MIURA, SHINJI ET AL.: "Antitumor activity of a novel orally effective nucleoside , 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine", CANCER LETTERS, vol. 129, 1998, pages 103 - 110, XP055213439, doi:10.1016/S0304-3835(98)00089-5
MIURA, SHINJI ET AL.: "Comparison of 1-(2-deoxy-2-fluoro-4-thio- beta -D-arabinofuranosyl)cytosine with gemcitabine in its antitumor activity", CANCER LETTERS, vol. 144, 1999, pages 177 - 182, XP055213437, doi:10.1016/S0304-3835(99)00221-9
Attorney, Agent or Firm:
SIKS & CO. (JP)
Download PDF: